Ovarian Tissue Cryopreservation in Females Undergoing Procedures That Will Potentially Lead To Loss of Ovarian Function
Completed · Not applicable
Conditions studied: Cancer, Effects of Chemotherapy, Unspecified Complication of Bone Marrow Transplant, Auto Immune Disease
In brief
The purpose of this study is to retrieve and cryopreserve ovarian tissue from females undergoing a treatment that may lead to irreversible loss of ovarian function.
Key facts
- Study ID
- NCT01993732
- Run by
- Medical College of Wisconsin
- People needed
- 15
- Starts
- 2013-08-06
- Expected to finish
- 2018-06-28
- Last updated by the study team
- 2019-08-14
Who can join
Age: 3 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patient must be female.
- Patient must have a disease process where the disease or its treatment adversely affects ovarian function.
- Patient must be recommended for this study by their oncologist or specialist.
- Patient (or legally authorized representative) must sign an informed consent.
You may not qualify if…
- Patients cannot be male.
- Patients must not be HIV positive.
- Patient cannot have a poor diagnosis such that she is not expected to survive to adulthood.
- Patient cannot have any medical condition that would contraindicate surgery.
- Patient cannot have any medical condition that would contraindicate general anesthesia.
- Patient cannot have any medical condition that would contraindicate pregnancy.
Where it is running
- Children's Hospital of Wisconsin — Milwaukee, Wisconsin, United States
- Froedtert and The Medical College of Wisconsin — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.